Although this difference did not reach statistical significance (P = 0.500), the results suggest that specific antibody types may be potentially associated with disease progression and treatment response ( Table 3 ).
← all excerpts
Evaluation of warning strategies for paraneoplastic neurological syndromes associated with PD-1/PD-L1 inhibitors.
1
0.5000
0.5000